Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study

Clinical trial NCT06651203 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06651203
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Mycosis Fungoides/Sezary Syndrome Cutaneous T Cell Lymphoma

Start date: 2024-11-01
Primary completion: 2027-11-01
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.